Hanwha Life Insurance Co., Ltd. (088350.KS)
Seoul, KR
Based in Seoul, South Korea, Hanwha Life Insurance Co., Ltd. serves a diverse clientele of individuals and businesses, extending its financial protection offerings across South Korea, Vietnam, China, Indonesia, and other global regions. The company's extensive product suite encompasses various insurance types, including health, retirement, investment, group, accident, and savings plans, alongside retirement pension schemes, specialized consulting, and asset management solutions. These services are made available through a wide array of distribution networks, including individual and group financial planners, general agencies, bancassurance arrangements, and online platforms. Founded in 1946, the firm operated as Korea Life Insurance Co., Ltd. until October 2012, when it officially adopted its present name.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.11% | -13.48% | -0.10% | -1.51% | +62.13% | +50.15% | +65.14% | +93.27% | +26.75% | -23.63% | -44.86% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | +2 |
| Buy | 4 | +2 |
| Hold | 4 | -1 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Insurance - Life: +10.6%+64.7% ★ Q1'26: +116.1% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-1.4% Q1'26: +32.1% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+7.8% Q1'26: +20.4% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+4.1% Q1'26: +4.9% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+1.8% ★ Q1'26: +3.3% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+14.6% Q1'26: +36.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×27.58× Q1'26: 16.17× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 12 EPS Ana. |
Dec 2027 1 Rev. Ana. 11 EPS Ana. |
Dec 2028 1 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
14.95T
est: 13.99T (+6.9%)
|
17.22T
est: 14.82T (+16.2%)
|
21.15T
est: 14.08T (+50.2%)
|
21.50T
est: 13.81T (+55.8%)
|
18.99T
est: 13.16T (+44.3%)
|
20.13T
est: 14.40T (+39.7%)
|
21.13T
est: 14.06T (+50.3%)
|
14.08T
est: 14.15T (-0.5%)
|
17.17T
est: 24.85T (-30.9%)
|
16.66T
est: 30.34T (-45.1%)
|
27.44T
est: 35.47T (-22.6%)
|
39.38T
39.38T – 39.38T
+11.0% YoY
|
4.45T
4.45T – 4.45T
-88.7% YoY
|
39.15T
39.15T – 39.15T
+779.1% YoY
|
| EBITDA |
713.20B
est: 1.31T (-45.4%)
|
1.19T
est: 1.38T (-14.0%)
|
1.20T
est: 1.31T (-8.5%)
|
861.97B
est: 1.29T (-33.1%)
|
307.46B
est: 1.23T (-75.0%)
|
565.05B
est: 1.34T (-58.0%)
|
1.93T
est: 1.31T (+47.4%)
|
1.90T
est: 1.32T (+44.2%)
|
1.72T
est: 2.32T (-26.0%)
|
1.86T
est: 2.91T (-36.0%)
|
1.13T
est: 3.40T (-66.7%)
|
3.78T
3.78T – 3.78T
+11.0% YoY
|
427.35B
427.35B – 427.35B
-88.7% YoY
|
3.76T
3.76T – 3.76T
+779.1% YoY
|
| EBIT |
607.03B
est: 1.12T (-45.8%)
|
1.01T
est: 1.19T (-14.8%)
|
963.70B
est: 1.13T (-14.4%)
|
630.01B
est: 1.10T (-42.9%)
|
34.88B
est: 1.05T (-96.7%)
|
274.92B
est: 1.15T (-76.1%)
|
1.66T
est: 1.12T (+47.5%)
|
1.65T
est: 1.13T (+45.8%)
|
1.55T
est: 1.99T (-21.9%)
|
1.67T
est: 2.59T (-35.7%)
|
1.13T
est: 3.03T (-62.7%)
|
3.37T
3.37T – 3.37T
+11.0% YoY
|
380.80B
380.80B – 380.80B
-88.7% YoY
|
3.35T
3.35T – 3.35T
+779.1% YoY
|
| Net Income |
530.09B
est: 504.99B (+5.0%)
|
795.34B
est: 408.28B (+94.8%)
|
584.94B
est: 572.41B (+2.2%)
|
415.27B
est: 439.60B (-5.5%)
|
100.42B
est: 67.10B (+49.7%)
|
202.11B
est: 197.14B (+2.5%)
|
1.19T
est: 393.62B (+202.7%)
|
1.03T
est: 323.81B (+218.2%)
|
758.48B
est: 672.52B (+12.8%)
|
737.25B
est: 773.62B (-4.7%)
|
801.00B
est: 427.12B (+87.5%)
|
634.20B
634.20B – 922.75B
+48.5% YoY
|
685.71B
685.71B – 883.73B
+8.1% YoY
|
688.78B
688.78B – 688.78B
+0.4% YoY
|
| SGA |
475.26B
est: 392.92B (+21.0%)
|
648.36B
est: 416.11B (+55.8%)
|
800.89B
est: 395.39B (+102.6%)
|
765.53B
est: 387.71B (+97.4%)
|
879.21B
est: 369.68B (+137.8%)
|
859.73B
est: 404.54B (+112.5%)
|
642.61B
est: 394.84B (+62.8%)
|
331.24B
est: 397.53B (-16.7%)
|
349.71B
est: 698.03B (-49.9%)
|
389.95B
est: 592.98B (-34.2%)
|
—
est: 693.09B (-100.0%)
|
769.49B
769.49B – 769.49B
+11.0% YoY
|
87.03B
87.03B – 87.03B
-88.7% YoY
|
765.03B
765.03B – 765.03B
+779.1% YoY
|
| EPS |
658.00
est: 666.48 (-1.3%)
|
1,058.00
est: 538.84 (+96.3%)
|
757.00
est: 755.47 (+0.2%)
|
473.00
est: 580.18 (-18.5%)
|
48.92
est: 88.55 (-44.8%)
|
140.42
est: 260.19 (-46.0%)
|
1,455.16
est: 519.50 (+180.1%)
|
972.78
est: 427.36 (+127.6%)
|
1,003.84
est: 887.59 (+13.1%)
|
935.61
est: 890.72 (+5.0%)
|
922.24
est: 491.77 (+87.5%)
|
730.20
730.20 – 1,062.43
+48.5% YoY
|
789.50
789.50 – 1,017.50
+8.1% YoY
|
793.05
793.05 – 793.05
+0.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 2/5 | 2/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 2/5 | 2/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 2/5 | 2/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 2/5 | 2/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-15 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dong Won Kim | Vice President & Chief Digital Strategy Officer | 1B | male |
| Jung-Won Kim | MD & Head of Compliance | 752M | male |
| Dong-Hee Kim | Head of Finance | — | male |
| Hyeuk-Woong Kwon | Vice-Chairman & Chief Executive Officer | — | — |
| Kyung Geun Lee | Internal Accounting Manager | — | — |
| Kyung-Keun Lee | President, CEO & Director | — | male |
| Minsik Shin | MD, Head of Investment Division & Head of Investment Business Division | — | male |
| Nam-Gyu Cha | Adviser | — | male |
| Byeong-Seon Choi | Executive Director of Legal Team | — | male |
| Sang-Wook Choi | Investor Relations Head | — | male |
| Do Kyo Gu | Head of Private Sales Division & Executive Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 088350.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
